Dr. Joshua Grill, executive director at UCI MIND – the organization at UC Irvine that’s technically known as the Institute for Memory Impairments and Neurological Disorders and is widely regarded as one of the nation’s most important hubs for research into Alzheimer’s disease and other forms of dementia – is an expert at running scientific clinical trials.

And while such trials can be wildly technical and arcane, most boil down to a fairly simple question of cause and effect. If you introduce a cause (by giving a trial participant an experimental drug, or a placebo, or a back rub, or whatever), will it produce an effect (robust health, no physical change at all, annoying rash, etc.)?

So it’s maybe more than a little ironic that even Grill, expert that he is, couldn’t possibly have forese

See Full Page